Our mission is to outsmart cancer

By uniquely bringing Patient Selection into the
Target Identification stage.

Using the best model human

By using real patients data, we integrate target identification with cohort selection into a single coherent strategy.

Using best data patient tumor whole genome data

We use 100% of Genome Data, both Exome & Dark Genome alterations.
With a wealth of patient-derived tumor data, we can identify
novel drug targets “invisible” in cell line-based assays.